[Prevention of peritonitis in patients with peritoneal dialysis].
Ivarsen
Per Ramløv
PR
Skejby Sygehus, Arhus Universitetshospital, Nyremedicinsk Afdeling C og Klinisk Mikrobiologisk Afdeling.
Møller
Jens Kjølseth
JK
Povlsen
Johan Vestergaard
JV
D000281:Administration, Intranasal; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D016712:Mupirocin / Q000008:administration & dosage*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D000900:Anti-Bacterial Agents; D016712:Mupirocin